GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight in obese mice
S. Sachs, A. Goetz, B. Finan, R. D. DiMarchi, Y. Doering, C. Weber, M. Tschoep, T. D. Mueller, S. M. Hofmann
This study shows that GIP receptor agonism reduces dyslipidemia and atherosclerosis in obese mice without affecting body weight.
bioRxiv · Mar 15, 2022 · PreprintPharmacology & Toxicology